486414-83-9 Usage
General Description
(1-Methyl-1H-imidazol-4-yl)methylamine is a chemical compound with the molecular formula C5H10N2. It is an organic amine that contains an imidazole ring and a methylamine group. (1-Methyl-1H-imidazol-4-yl)methylamine is commonly used as a building block in organic synthesis, especially in the pharmaceutical industry. It has been studied for its potential as a ligand in metal-mediated catalysis, and as a precursor for the synthesis of various bioactive molecules. (1-Methyl-1H-imidazol-4-yl)methylamine is also known for its role as an intermediate in the production of pharmaceuticals and agrochemicals. Overall, this chemical compound has numerous applications across different sectors, particularly in the field of drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 486414-83-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,6,4,1 and 4 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 486414-83:
(8*4)+(7*8)+(6*6)+(5*4)+(4*1)+(3*4)+(2*8)+(1*3)=179
179 % 10 = 9
So 486414-83-9 is a valid CAS Registry Number.
486414-83-9Relevant articles and documents
HETEROARYL ALKYLENE SUBSTITUTED 2-OXOQUINAZOLINE DERIVATIVES AS INHIBITORS OF METHIONINE ADENOSYLTRANSFERASE 2A
-
, (2021/12/31)
Disclosed herein are certain heteroaryl alkylene substituted 2-oxoquinazoline derivatives of Formula (I): (I) that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.
Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use
-
Page 38, (2010/02/03)
Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically active metabolites, and pharmaceutically acceptable salts of said metabolites are described. These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.
